• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

How NLP can Uncover Social Determinants of Heart Disease

Share:

March 31, 2021

Heart disease is the leading cause of death for people of most racial and ethnic groups in the United States. Cardiovascular disease-related deaths—which occur every 36 seconds—cost our country about $219 billion each year, according to the Centers for Disease Control and Prevention (CDC). People with poor cardiovascular health are also at increased risk of severe illness from COVID-19, so the time to act is now. There’s no time like the present to look at major risk factors—from obesity and smoking to high cholesterol and blood pressure—and how to avoid them.

While acute care and medications exist to treat heart disease and other cardiovascular conditions, too often we look at how to manage ailments that already exist, rather than how to prevent them in the first place. While heart disease does affect a massive group of the population, like many diseases, it does discriminate, and without looking at the full spectrum of a patient’s life, it’s impossible to get to the root cause. In recent years, natural language processing (NLP) technology has been used to analyze social determinants of health to uncover helpful, or potentially dangerous, information about patients that may help us understand more about the disease.

Source: Hitconsultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Wolters Kluwer Targets Health Equity with Best Care EverywhereWolters Kluwer Targets Health Equity with Best Care Everywhere
  • 61 Health Tech Companies Report 2018 Revenues, Feature On Inc. 5,000 List61 Health Tech Companies Report 2018 Revenues, Feature On Inc. 5,000 List
  • Australis Enters Letter of Intent to Acquire Rthm Technologies Inc.Australis Enters Letter of Intent to Acquire Rthm Technologies Inc.
  • Mediolanum Farmaceutici Acquires the French Company ElsaLys Biotech to Develop Next Generation Immuno-oncology Therapies
  • Frontier Medicines launches with $67M and biotech veteran Varma as CEOFrontier Medicines launches with $67M and biotech veteran Varma as CEO
  • Smith Technologies Completes Acquisition by Francisco Partners and Rebrands as RedSail TechnologiesSmith Technologies Completes Acquisition by Francisco Partners and Rebrands as RedSail Technologies
  • Potential of Artificial Intelligence in Healthcare SectorPotential of Artificial Intelligence in Healthcare Sector
  • Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 TestCue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications